ProfileGDS4718 / 1565868_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 19% 19% 21% 19% 22% 40% 41% 20% 19% 16% 21% 27% 20% 32% 42% 25% 20% 39% 39% 54% 23% 20% 19% 14% 18% 30% 11% 31% 27% 40% 30% 37% 8% 12% 27% 38% 23% 22% 18% 20% 23% 37% 35% 23% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1026819
GSM549102patient 115, normal, homogenized [OPG study]4.1345119
GSM549104patient 119, normal, homogenized [OPG study]4.1485321
GSM549108patient 138, normal, homogenized [OPG study]4.1541719
GSM549119patient 077, normal, homogenized [OPG study]4.2269422
GSM549133patient 032, cancer, homogenized [OPG study]4.9238840
GSM549139patient 042, cancer, homogenized [OPG study]5.0016741
GSM549099patient 107, normal, homogenized [OPG study]4.157320
GSM549109patient 139, normal, homogenized [OPG study]4.1411719
GSM549110patient 046, normal, homogenized [OPG study]4.0125516
GSM549114patient 063, normal, homogenized [OPG study]4.1302421
GSM549122patient 082, normal, homogenized [OPG study]4.4278327
GSM549134patient 033, cancer, homogenized [OPG study]4.1301120
GSM549136patient 036, cancer, homogenized [OPG study]4.5758932
GSM549140patient 044, cancer, homogenized [OPG study]5.0382242
GSM549111patient 047, normal, homogenized [OPG study]4.3051325
GSM549113patient 057, normal, homogenized [OPG study]4.1050520
GSM549132patient 031, cancer, homogenized [OPG study]4.9302139
GSM549137patient 038, cancer, homogenized [OPG study]4.9252139
GSM549142patient 047, cancer, homogenized [OPG study]5.8500354
GSM549100patient 110, normal, homogenized [OPG study]4.2789823
GSM549107patient 135, normal, homogenized [OPG study]4.1145620
GSM549115patient 068, normal, homogenized [OPG study]4.0528419
GSM549116patient 072, normal, homogenized [OPG study]3.9016814
GSM549120patient 078, normal, homogenized [OPG study]4.0665718
GSM549131patient 030, cancer, homogenized [OPG study]4.4914530
GSM549118patient 074, normal, homogenized [OPG study]3.8226311
GSM549129patient 027, cancer, homogenized [OPG study]4.6134231
GSM549123patient 088, normal, homogenized [OPG study]4.4004727
GSM549124patient 006, cancer, homogenized [OPG study]5.0322240
GSM549126patient 015, cancer, homogenized [OPG study]4.5396130
GSM549128patient 025, cancer, homogenized [OPG study]4.8476137
GSM549103patient 117, normal, homogenized [OPG study]3.718858
GSM549117patient 073, normal, homogenized [OPG study]3.8631512
GSM549138patient 041, cancer, homogenized [OPG study]4.4063627
GSM549141patient 045, cancer, homogenized [OPG study]4.8358638
GSM549130patient 028, cancer, homogenized [OPG study]4.2630823
GSM549101patient 111, normal, homogenized [OPG study]4.2456722
GSM549105patient 128, normal, homogenized [OPG study]4.0919118
GSM549106patient 134, normal, homogenized [OPG study]4.1120720
GSM549112patient 048, normal, homogenized [OPG study]4.253323
GSM549125patient 011, cancer, homogenized [OPG study]4.8797737
GSM549127patient 024, cancer, homogenized [OPG study]4.7636135
GSM549135patient 035, cancer, homogenized [OPG study]4.2033923